Trial
NCT04522466
Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang
Condition
Sars-CoV2
Intervention
Hydroxychloroquine (HCQ)
Why stopped
Stop of the study by competent authority (ANSM)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-07